Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.53228672 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.53228672 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.53228672 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.53228672 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.53228672 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.53228672 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.54622496 |
8 | macrophage activation involved in immune response (GO:0002281) | 4.83143983 |
9 | detection of other organism (GO:0098543) | 4.75878625 |
10 | positive regulation of interferon-alpha production (GO:0032727) | 4.66479396 |
11 | detection of bacterium (GO:0016045) | 4.61762989 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58816024 |
13 | regulation of interferon-alpha production (GO:0032647) | 4.45081778 |
14 | response to peptidoglycan (GO:0032494) | 4.42490814 |
15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39419858 |
16 | neutrophil activation involved in immune response (GO:0002283) | 4.32999794 |
17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29788511 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29788511 |
19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.29550566 |
20 | response to host immune response (GO:0052572) | 4.26164054 |
21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.26164054 |
22 | immunoglobulin mediated immune response (GO:0016064) | 4.16096181 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11329761 |
24 | detection of external biotic stimulus (GO:0098581) | 4.07747593 |
25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.03363440 |
26 | response to host (GO:0075136) | 4.03363440 |
27 | response to host defenses (GO:0052200) | 4.03363440 |
28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88007754 |
29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77403791 |
30 | negative regulation of cell killing (GO:0031342) | 3.72921851 |
31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72921851 |
32 | microglial cell activation (GO:0001774) | 3.71120985 |
33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69016759 |
34 | detection of biotic stimulus (GO:0009595) | 3.68388102 |
35 | response to muramyl dipeptide (GO:0032495) | 3.61030730 |
36 | respiratory burst (GO:0045730) | 3.57633649 |
37 | positive regulation of B cell differentiation (GO:0045579) | 3.55503848 |
38 | negative regulation of interleukin-12 production (GO:0032695) | 3.54400601 |
39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45937958 |
40 | positive regulation of interferon-beta production (GO:0032728) | 3.43149039 |
41 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.41653534 |
42 | I-kappaB phosphorylation (GO:0007252) | 3.40792537 |
43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.39645337 |
44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34270183 |
45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33810129 |
46 | myeloid cell activation involved in immune response (GO:0002275) | 3.31128412 |
47 | macrophage activation (GO:0042116) | 3.28586927 |
48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20716783 |
49 | regulation of leukocyte degranulation (GO:0043300) | 3.20096762 |
50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19824565 |
51 | response to type I interferon (GO:0034340) | 3.16845013 |
52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.16333101 |
53 | natural killer cell mediated immunity (GO:0002228) | 3.16333101 |
54 | type I interferon signaling pathway (GO:0060337) | 3.15654426 |
55 | cellular response to type I interferon (GO:0071357) | 3.15654426 |
56 | granulocyte activation (GO:0036230) | 3.15444235 |
57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15393562 |
58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13818133 |
59 | T-helper 1 type immune response (GO:0042088) | 3.12253917 |
60 | regulation of cholesterol storage (GO:0010885) | 3.10704687 |
61 | neutrophil activation (GO:0042119) | 3.10119808 |
62 | regulation of antigen processing and presentation (GO:0002577) | 3.09356980 |
63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.08610465 |
64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07472939 |
65 | regulation of T cell tolerance induction (GO:0002664) | 3.06158333 |
66 | positive regulation of mast cell degranulation (GO:0043306) | 3.05384276 |
67 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05384276 |
68 | defense response to protozoan (GO:0042832) | 3.05042358 |
69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04114050 |
70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02465349 |
71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01880133 |
72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98835461 |
73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98806428 |
74 | activated T cell proliferation (GO:0050798) | 2.98040207 |
75 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.97809394 |
76 | regulation of tolerance induction (GO:0002643) | 2.96953865 |
77 | pinocytosis (GO:0006907) | 2.94615890 |
78 | neutrophil mediated immunity (GO:0002446) | 2.94156143 |
79 | B cell mediated immunity (GO:0019724) | 2.94130805 |
80 | regulation of B cell differentiation (GO:0045577) | 2.92042835 |
81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91584450 |
82 | B cell receptor signaling pathway (GO:0050853) | 2.91499305 |
83 | germinal center formation (GO:0002467) | 2.91467603 |
84 | negative thymic T cell selection (GO:0045060) | 2.90984564 |
85 | response to interleukin-15 (GO:0070672) | 2.88617465 |
86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.88127044 |
87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.87285092 |
88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86283653 |
89 | T cell migration (GO:0072678) | 2.83099256 |
90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.81300642 |
91 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.81087305 |
92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.81087305 |
93 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80429296 |
94 | negative T cell selection (GO:0043383) | 2.80339297 |
95 | apoptotic cell clearance (GO:0043277) | 2.80199950 |
96 | low-density lipoprotein particle clearance (GO:0034383) | 2.80028237 |
97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79816033 |
98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79056187 |
99 | NIK/NF-kappaB signaling (GO:0038061) | 2.78300759 |
100 | regulation of mast cell degranulation (GO:0043304) | 2.77711837 |
101 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.77595990 |
102 | cellular extravasation (GO:0045123) | 2.77290444 |
103 | negative regulation of interleukin-6 production (GO:0032715) | 2.77117259 |
104 | detection of molecule of bacterial origin (GO:0032490) | 2.76793994 |
105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76381092 |
106 | positive regulation of type 2 immune response (GO:0002830) | 2.75676932 |
107 | T cell selection (GO:0045058) | 2.75395547 |
108 | regulation of mononuclear cell migration (GO:0071675) | 2.74904220 |
109 | negative regulation of granulocyte differentiation (GO:0030853) | 2.74073680 |
110 | response to protozoan (GO:0001562) | 2.73288291 |
111 | response to interferon-alpha (GO:0035455) | 2.72374085 |
112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70490872 |
113 | positive T cell selection (GO:0043368) | 2.69733454 |
114 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.69523989 |
115 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.69182311 |
116 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68652714 |
117 | leukocyte aggregation (GO:0070486) | 2.67507553 |
118 | regulation of interferon-beta production (GO:0032648) | 2.67157590 |
119 | negative regulation of lipid storage (GO:0010888) | 2.67009554 |
120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66913586 |
121 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63173028 |
122 | positive regulation of humoral immune response (GO:0002922) | 2.60881070 |
123 | positive regulation of mast cell activation (GO:0033005) | 2.59095369 |
124 | myeloid dendritic cell differentiation (GO:0043011) | 2.57407998 |
125 | leukocyte mediated cytotoxicity (GO:0001909) | 2.57222943 |
126 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.55394236 |
127 | myeloid dendritic cell activation (GO:0001773) | 2.53241023 |
128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52962050 |
129 | regulation of interleukin-12 production (GO:0032655) | 2.52838040 |
130 | regulation of mast cell activation (GO:0033003) | 2.52033193 |
131 | positive thymic T cell selection (GO:0045059) | 2.51722273 |
132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.50467013 |
133 | myeloid leukocyte activation (GO:0002274) | 2.50244650 |
134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50099680 |
135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.49814734 |
136 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.49550599 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.50868344 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.38658692 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31891423 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.91804312 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.89501071 |
6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.46896966 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37378777 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20427905 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14521918 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.06157349 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94510022 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94160495 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84260924 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83832074 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73933847 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.60067277 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.38940089 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37223362 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37035580 |
20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.36505131 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32834641 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30165081 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28409837 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 2.07897311 |
25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06382168 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03427935 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00208004 |
28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99007369 |
29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97516067 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93908405 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.93471348 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 1.91613208 |
33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.89872275 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81519431 |
35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80273839 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78311106 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78172625 |
38 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76607772 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72577645 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72434235 |
41 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72322356 |
42 | MYB_26560356_Chip-Seq_TH2_Human | 1.70434281 |
43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68457209 |
44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67264373 |
45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65853050 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.64183731 |
47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61952050 |
48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54771251 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48684502 |
50 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48069743 |
51 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47479690 |
52 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47201528 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45751620 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44009063 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42692294 |
56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42138768 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39230738 |
58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36497798 |
59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35389321 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32740555 |
61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32118642 |
62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31983254 |
63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31922313 |
64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27307265 |
65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26695559 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25947083 |
67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24822387 |
68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23112858 |
69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23101445 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22544898 |
71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22252418 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20011669 |
73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18595664 |
74 | MAF_26560356_Chip-Seq_TH2_Human | 1.18193510 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16523010 |
76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15649195 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12574270 |
78 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11560090 |
79 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.11197101 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10601314 |
81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09962607 |
82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08765874 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07300478 |
84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06970443 |
85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06838421 |
86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05792045 |
87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05183774 |
88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03412559 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02600842 |
90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01363270 |
91 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00540504 |
92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97948404 |
93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97602431 |
94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97331541 |
95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95304515 |
96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94489256 |
97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93969388 |
98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93884624 |
99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93665650 |
100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90608970 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89372993 |
102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87341940 |
103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87293456 |
104 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86132589 |
105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83947578 |
106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83870650 |
107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83754555 |
108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82790072 |
109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82742492 |
110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.82450756 |
111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82021857 |
112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81393123 |
113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80382217 |
114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79246400 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79060494 |
116 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78839977 |
117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78035805 |
118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77821941 |
119 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76226389 |
120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76191453 |
121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75904554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.77419499 |
2 | MP0003303_peritoneal_inflammation | 3.70296689 |
3 | MP0005058_abnormal_lysosome_morphology | 3.56528845 |
4 | MP0003436_decreased_susceptibility_to | 3.43096679 |
5 | MP0000569_abnormal_digit_pigmentation | 2.97653241 |
6 | MP0009840_abnormal_foam_cell | 2.80614591 |
7 | * MP0002419_abnormal_innate_immunity | 2.79537865 |
8 | MP0001790_abnormal_immune_system | 2.75275614 |
9 | MP0005387_immune_system_phenotype | 2.75275614 |
10 | MP0003172_abnormal_lysosome_physiology | 2.64228604 |
11 | MP0005000_abnormal_immune_tolerance | 2.62406468 |
12 | * MP0001800_abnormal_humoral_immune | 2.58344867 |
13 | MP0000685_abnormal_immune_system | 2.56569882 |
14 | MP0009785_altered_susceptibility_to | 2.54623265 |
15 | * MP0002452_abnormal_antigen_presenting | 2.49217982 |
16 | MP0005025_abnormal_response_to | 2.47022743 |
17 | MP0005464_abnormal_platelet_physiology | 2.35235373 |
18 | * MP0002723_abnormal_immune_serum | 2.30995514 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.29692561 |
20 | MP0003300_gastrointestinal_ulcer | 2.27314213 |
21 | * MP0006082_CNS_inflammation | 2.17225240 |
22 | MP0002148_abnormal_hypersensitivity_rea | 2.12454435 |
23 | MP0005671_abnormal_response_to | 2.12372820 |
24 | * MP0001819_abnormal_immune_cell | 2.05565928 |
25 | * MP0002420_abnormal_adaptive_immunity | 2.04748909 |
26 | MP0009278_abnormal_bone_marrow | 2.02435402 |
27 | MP0003724_increased_susceptibility_to | 1.89095029 |
28 | MP0003828_pulmonary_edema | 1.81221966 |
29 | * MP0004947_skin_inflammation | 1.76686761 |
30 | * MP0001845_abnormal_inflammatory_respons | 1.71012859 |
31 | * MP0001533_abnormal_skeleton_physiology | 1.70431504 |
32 | MP0005360_urolithiasis | 1.70416977 |
33 | MP0000604_amyloidosis | 1.66876117 |
34 | * MP0002405_respiratory_system_inflammati | 1.64475686 |
35 | * MP0008469_abnormal_protein_level | 1.61240076 |
36 | * MP0000716_abnormal_immune_system | 1.61218036 |
37 | * MP0002398_abnormal_bone_marrow | 1.57012872 |
38 | * MP0000689_abnormal_spleen_morphology | 1.55009492 |
39 | MP0002139_abnormal_hepatobiliary_system | 1.54328458 |
40 | MP0002166_altered_tumor_susceptibility | 1.53797902 |
41 | MP0001853_heart_inflammation | 1.53148088 |
42 | MP0003448_altered_tumor_morphology | 1.45027269 |
43 | MP0002254_reproductive_system_inflammat | 1.44135901 |
44 | MP0004883_abnormal_blood_vessel | 1.43939891 |
45 | MP0003183_abnormal_peptide_metabolism | 1.43714286 |
46 | MP0010155_abnormal_intestine_physiology | 1.42048040 |
47 | * MP0004510_myositis | 1.40275195 |
48 | MP0003866_abnormal_defecation | 1.36889509 |
49 | MP0009764_decreased_sensitivity_to | 1.36023624 |
50 | MP0005257_abnormal_intraocular_pressure | 1.35358529 |
51 | MP0005174_abnormal_tail_pigmentation | 1.34687502 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.33423665 |
53 | * MP0002429_abnormal_blood_cell | 1.32889898 |
54 | * MP0002722_abnormal_immune_system | 1.32574894 |
55 | MP0001545_abnormal_hematopoietic_system | 1.30773681 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.30773681 |
57 | MP0003705_abnormal_hypodermis_morpholog | 1.29892405 |
58 | MP0003075_altered_response_to | 1.28566987 |
59 | MP0002006_tumorigenesis | 1.28193404 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.27314627 |
61 | MP0004381_abnormal_hair_follicle | 1.25360705 |
62 | MP0002396_abnormal_hematopoietic_system | 1.24602738 |
63 | MP0010307_abnormal_tumor_latency | 1.22413150 |
64 | MP0005076_abnormal_cell_differentiation | 1.21273968 |
65 | MP0003690_abnormal_glial_cell | 1.19013408 |
66 | * MP0002998_abnormal_bone_remodeling | 1.18763910 |
67 | MP0002132_abnormal_respiratory_system | 1.16876249 |
68 | MP0000343_altered_response_to | 1.16729081 |
69 | MP0003566_abnormal_cell_adhesion | 1.15674481 |
70 | MP0005310_abnormal_salivary_gland | 1.15364630 |
71 | MP0003656_abnormal_erythrocyte_physiolo | 1.12871057 |
72 | MP0002277_abnormal_respiratory_mucosa | 1.11799176 |
73 | * MP0000609_abnormal_liver_physiology | 1.09363696 |
74 | MP0005083_abnormal_biliary_tract | 1.08946561 |
75 | MP0002138_abnormal_hepatobiliary_system | 1.08539342 |
76 | MP0009763_increased_sensitivity_to | 1.06614943 |
77 | MP0005166_decreased_susceptibility_to | 1.04027345 |
78 | MP0005365_abnormal_bile_salt | 1.03638923 |
79 | * MP0001851_eye_inflammation | 1.03166833 |
80 | MP0003252_abnormal_bile_duct | 1.01508742 |
81 | MP0000858_altered_metastatic_potential | 1.01219045 |
82 | MP0005167_abnormal_blood-brain_barrier | 0.99052637 |
83 | MP0004808_abnormal_hematopoietic_stem | 0.96852618 |
84 | MP0003763_abnormal_thymus_physiology | 0.92894483 |
85 | MP0005451_abnormal_body_composition | 0.92648308 |
86 | MP0010329_abnormal_lipoprotein_level | 0.89973120 |
87 | * MP0001663_abnormal_digestive_system | 0.89281578 |
88 | MP0003453_abnormal_keratinocyte_physiol | 0.88070641 |
89 | MP0005023_abnormal_wound_healing | 0.87827098 |
90 | MP0008004_abnormal_stomach_pH | 0.87748260 |
91 | MP0004130_abnormal_muscle_cell | 0.87697457 |
92 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86158529 |
93 | MP0003045_fibrosis | 0.85803347 |
94 | MP0003091_abnormal_cell_migration | 0.83858850 |
95 | MP0000371_diluted_coat_color | 0.82426125 |
96 | MP0000598_abnormal_liver_morphology | 0.81938613 |
97 | MP0000703_abnormal_thymus_morphology | 0.79685253 |
98 | * MP0002933_joint_inflammation | 0.79591368 |
99 | MP0002136_abnormal_kidney_physiology | 0.78923161 |
100 | * MP0001873_stomach_inflammation | 0.78791768 |
101 | MP0000767_abnormal_smooth_muscle | 0.77328391 |
102 | MP0008260_abnormal_autophagy | 0.75856039 |
103 | * MP0005390_skeleton_phenotype | 0.75532663 |
104 | MP0000249_abnormal_blood_vessel | 0.74373080 |
105 | MP0005085_abnormal_gallbladder_physiolo | 0.73250905 |
106 | MP0002009_preneoplasia | 0.73026577 |
107 | MP0001958_emphysema | 0.72526470 |
108 | MP0000490_abnormal_crypts_of | 0.71074175 |
109 | MP0002332_abnormal_exercise_endurance | 0.69990434 |
110 | MP0009765_abnormal_xenobiotic_induced | 0.69540140 |
111 | MP0003279_aneurysm | 0.68838481 |
112 | MP0000015_abnormal_ear_pigmentation | 0.68618703 |
113 | MP0001915_intracranial_hemorrhage | 0.68025613 |
114 | MP0001986_abnormal_taste_sensitivity | 0.67605068 |
115 | MP0005164_abnormal_response_to | 0.66675733 |
116 | * MP0005319_abnormal_enzyme/_coenzyme | 0.66234090 |
117 | * MP0003795_abnormal_bone_structure | 0.65275626 |
118 | MP0009115_abnormal_fat_cell | 0.64827596 |
119 | MP0003879_abnormal_hair_cell | 0.60518671 |
120 | MP0008874_decreased_physiological_sensi | 0.58570319 |
121 | MP0002693_abnormal_pancreas_physiology | 0.52064056 |
122 | * MP0005381_digestive/alimentary_phenotyp | 0.50442152 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.85354365 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.55731810 |
3 | Eczematoid dermatitis (HP:0000976) | 5.22916895 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.99911832 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.71269421 |
6 | Increased cerebral lipofuscin (HP:0011813) | 4.44554853 |
7 | Abnormality of macrophages (HP:0004311) | 4.11988187 |
8 | Vacuolated lymphocytes (HP:0001922) | 4.04146989 |
9 | Increased IgE level (HP:0003212) | 3.70880858 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.67674088 |
11 | Glomerulonephritis (HP:0000099) | 3.65449487 |
12 | Recurrent skin infections (HP:0001581) | 3.62480918 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.55121374 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53022441 |
15 | Myositis (HP:0100614) | 3.48973029 |
16 | Myocardial infarction (HP:0001658) | 3.46574690 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.44636778 |
18 | Keratoconjunctivitis sicca (HP:0001097) | 3.41896718 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.39609207 |
20 | Dysostosis multiplex (HP:0000943) | 3.33366578 |
21 | Disinhibition (HP:0000734) | 3.28825325 |
22 | Recurrent fungal infections (HP:0002841) | 3.28243303 |
23 | Complement deficiency (HP:0004431) | 3.21343189 |
24 | Gingivitis (HP:0000230) | 3.20914923 |
25 | Encephalitis (HP:0002383) | 3.17653602 |
26 | Keratoconjunctivitis (HP:0001096) | 3.14838717 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12244033 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12244033 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12244033 |
30 | Orchitis (HP:0100796) | 3.11226096 |
31 | Axonal loss (HP:0003447) | 3.09190748 |
32 | Hemoptysis (HP:0002105) | 3.05744178 |
33 | Periodontitis (HP:0000704) | 3.02263742 |
34 | Colitis (HP:0002583) | 3.02212075 |
35 | Stomatitis (HP:0010280) | 2.98708577 |
36 | Recurrent viral infections (HP:0004429) | 2.94083378 |
37 | Abnormality of T cell number (HP:0011839) | 2.92983651 |
38 | Mucopolysacchariduria (HP:0008155) | 2.92708338 |
39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92708338 |
40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92036642 |
41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92036642 |
42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92036642 |
43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.90951462 |
44 | Joint hemorrhage (HP:0005261) | 2.88516609 |
45 | Hypochromic anemia (HP:0001931) | 2.85357563 |
46 | Abnormality of complement system (HP:0005339) | 2.85190637 |
47 | Gingival bleeding (HP:0000225) | 2.84132800 |
48 | Pustule (HP:0200039) | 2.83388581 |
49 | Vasculitis (HP:0002633) | 2.82475974 |
50 | Cellulitis (HP:0100658) | 2.80062426 |
51 | Hematochezia (HP:0002573) | 2.75648415 |
52 | Loss of speech (HP:0002371) | 2.75498285 |
53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71666914 |
54 | Obstructive lung disease (HP:0006536) | 2.71666914 |
55 | Optic neuritis (HP:0100653) | 2.70592601 |
56 | Retrobulbar optic neuritis (HP:0100654) | 2.70592601 |
57 | T lymphocytopenia (HP:0005403) | 2.63645632 |
58 | Chest pain (HP:0100749) | 2.63639943 |
59 | Inflammation of the large intestine (HP:0002037) | 2.63179910 |
60 | Increased IgM level (HP:0003496) | 2.63003984 |
61 | Chronic otitis media (HP:0000389) | 2.57702555 |
62 | Nephritis (HP:0000123) | 2.56203250 |
63 | Pulmonary embolism (HP:0002204) | 2.53566315 |
64 | Spontaneous hematomas (HP:0007420) | 2.50425341 |
65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.49835326 |
66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.49835326 |
67 | Gastrointestinal inflammation (HP:0004386) | 2.48308275 |
68 | Episodic fever (HP:0001954) | 2.47561146 |
69 | Osteomyelitis (HP:0002754) | 2.44376440 |
70 | Arterial thrombosis (HP:0004420) | 2.42270232 |
71 | Thick nail (HP:0001805) | 2.42011443 |
72 | Panhypogammaglobulinemia (HP:0003139) | 2.40166157 |
73 | Interstitial pulmonary disease (HP:0006530) | 2.40018226 |
74 | Granulocytopenia (HP:0001913) | 2.39888310 |
75 | Urticaria (HP:0001025) | 2.36572827 |
76 | Gangrene (HP:0100758) | 2.34840937 |
77 | Meningitis (HP:0001287) | 2.33871473 |
78 | Upper motor neuron abnormality (HP:0002127) | 2.33451217 |
79 | Thoracic kyphosis (HP:0002942) | 2.32076295 |
80 | Abnormality of T cells (HP:0002843) | 2.30330585 |
81 | Impaired platelet aggregation (HP:0003540) | 2.30304219 |
82 | Abnormal platelet function (HP:0011869) | 2.30304219 |
83 | Deep venous thrombosis (HP:0002625) | 2.29725408 |
84 | Autoimmune hemolytic anemia (HP:0001890) | 2.28458295 |
85 | Peritonitis (HP:0002586) | 2.27558634 |
86 | Pathologic fracture (HP:0002756) | 2.27070553 |
87 | Basal ganglia calcification (HP:0002135) | 2.26546066 |
88 | Agammaglobulinemia (HP:0004432) | 2.26331144 |
89 | Hypochromic microcytic anemia (HP:0004840) | 2.24877651 |
90 | Metaphyseal cupping (HP:0003021) | 2.23729952 |
91 | Epistaxis (HP:0000421) | 2.23382001 |
92 | Hypergammaglobulinemia (HP:0010702) | 2.22477271 |
93 | Anorexia (HP:0002039) | 2.19683488 |
94 | Hepatosplenomegaly (HP:0001433) | 2.17609587 |
95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15860344 |
96 | Amyloidosis (HP:0011034) | 2.15321783 |
97 | Eosinophilia (HP:0001880) | 2.14752589 |
98 | Pulmonary infiltrates (HP:0002113) | 2.13935554 |
99 | Nasal polyposis (HP:0100582) | 2.13812652 |
100 | Abnormality of the pleura (HP:0002103) | 2.13623400 |
101 | Prostate neoplasm (HP:0100787) | 2.12072390 |
102 | Gastrointestinal stroma tumor (HP:0100723) | 2.10307758 |
103 | Leukocytosis (HP:0001974) | 2.09349752 |
104 | Abnormality of T cell physiology (HP:0011840) | 2.08559682 |
105 | Hypercholesterolemia (HP:0003124) | 2.08096657 |
106 | Sepsis (HP:0100806) | 2.05989568 |
107 | Increased serum ferritin (HP:0003281) | 2.05145869 |
108 | Purpura (HP:0000979) | 2.04325052 |
109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02847919 |
110 | Osteolytic defects of the hand bones (HP:0009699) | 2.02847919 |
111 | Xanthomatosis (HP:0000991) | 2.02729438 |
112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02499362 |
113 | Bone pain (HP:0002653) | 2.02489263 |
114 | Restrictive lung disease (HP:0002091) | 2.01833054 |
115 | Abnormality of the nasal mucosa (HP:0000433) | 2.01126250 |
116 | Premature loss of primary teeth (HP:0006323) | 2.01098745 |
117 | Asymmetric septal hypertrophy (HP:0001670) | 2.01050859 |
118 | Abnormality of iron homeostasis (HP:0011031) | 2.00670281 |
119 | Abnormality of the endocardium (HP:0004306) | 1.98921063 |
120 | Malnutrition (HP:0004395) | 1.98162676 |
121 | Lymphopenia (HP:0001888) | 1.97928489 |
122 | Prolonged bleeding time (HP:0003010) | 1.96748781 |
123 | Abnormality of the thoracic spine (HP:0100711) | 1.96745224 |
124 | Petechiae (HP:0000967) | 1.95752881 |
125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95727249 |
126 | Tetraparesis (HP:0002273) | 1.94756210 |
127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94733026 |
128 | Recurrent pneumonia (HP:0006532) | 1.92937479 |
129 | Acne (HP:0001061) | 1.92643280 |
130 | Mitral stenosis (HP:0001718) | 1.92561237 |
131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89982125 |
132 | Vertigo (HP:0002321) | 1.89578343 |
133 | IgM deficiency (HP:0002850) | 1.88810189 |
134 | Emphysema (HP:0002097) | 1.88110809 |
135 | Peripheral demyelination (HP:0011096) | 1.87914459 |
136 | Menorrhagia (HP:0000132) | 1.87820896 |
137 | Esophageal varix (HP:0002040) | 1.87715951 |
138 | Conjunctival telangiectasia (HP:0000524) | 1.86918511 |
139 | Skin ulcer (HP:0200042) | 1.86657991 |
140 | Global brain atrophy (HP:0002283) | 1.85146589 |
141 | Abnormality of the lumbar spine (HP:0100712) | 1.84290347 |
142 | Abnormality of the fingertips (HP:0001211) | 1.84187161 |
143 | Papilloma (HP:0012740) | 1.81903351 |
144 | Verrucae (HP:0200043) | 1.81903351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.00629017 |
2 | TYK2 | 3.19009139 |
3 | ERN1 | 3.17347412 |
4 | TBK1 | 3.01709056 |
5 | BLK | 2.83816937 |
6 | MAP3K14 | 2.73798263 |
7 | RIPK4 | 2.63952729 |
8 | TRIB3 | 2.59169987 |
9 | PRPF4B | 2.42238962 |
10 | JAK3 | 2.23816283 |
11 | MAP2K3 | 2.21493695 |
12 | IRAK4 | 2.21046858 |
13 | TAOK3 | 2.17543053 |
14 | IKBKE | 2.15445277 |
15 | TNK2 | 2.11953516 |
16 | TGFBR2 | 2.10761878 |
17 | CSF1R | 2.00125157 |
18 | JAK1 | 1.97543841 |
19 | IRAK3 | 1.97303533 |
20 | ZAP70 | 1.83623704 |
21 | SIK2 | 1.82639156 |
22 | IKBKB | 1.82291616 |
23 | MAP3K13 | 1.76391159 |
24 | CAMK1D | 1.75152755 |
25 | EPHB1 | 1.72263404 |
26 | CDK12 | 1.65894025 |
27 | CSK | 1.65331900 |
28 | MAP3K3 | 1.64273579 |
29 | HCK | 1.56951818 |
30 | STK10 | 1.53872625 |
31 | FGFR4 | 1.50212640 |
32 | PKN2 | 1.48420670 |
33 | MAP3K10 | 1.39889523 |
34 | FES | 1.38483361 |
35 | CAMK1G | 1.34353384 |
36 | BTK | 1.32111921 |
37 | PTK6 | 1.29077741 |
38 | CHUK | 1.27873688 |
39 | TXK | 1.23793649 |
40 | TTN | 1.20713706 |
41 | * KIT | 1.17992599 |
42 | * SYK | 1.15182700 |
43 | RPS6KA4 | 1.12882307 |
44 | NEK9 | 1.11619993 |
45 | CDC42BPA | 1.11389261 |
46 | JAK2 | 1.11158528 |
47 | LCK | 1.10506688 |
48 | GRK7 | 1.09910857 |
49 | FGR | 1.09704142 |
50 | MARK2 | 1.07038238 |
51 | MAPK7 | 1.01701458 |
52 | LYN | 1.01605821 |
53 | IRAK1 | 0.95392386 |
54 | MAP3K7 | 0.94037550 |
55 | SIK1 | 0.93946211 |
56 | LRRK2 | 0.92942650 |
57 | MAP3K6 | 0.91279116 |
58 | PRKD2 | 0.91003778 |
59 | EEF2K | 0.90292743 |
60 | GRK6 | 0.90275880 |
61 | CDK6 | 0.88563061 |
62 | PIM1 | 0.87332020 |
63 | FGFR3 | 0.85853468 |
64 | YES1 | 0.85796509 |
65 | MAP3K11 | 0.85157250 |
66 | SIK3 | 0.81731844 |
67 | ITK | 0.81481920 |
68 | RIPK1 | 0.80472517 |
69 | CAMKK2 | 0.77548925 |
70 | IRAK2 | 0.76833071 |
71 | TAOK1 | 0.76353148 |
72 | BMX | 0.74345404 |
73 | MATK | 0.72994457 |
74 | TAOK2 | 0.71356940 |
75 | MARK3 | 0.70839111 |
76 | RET | 0.70482028 |
77 | MAP2K6 | 0.70406235 |
78 | TEC | 0.69402059 |
79 | BMPR2 | 0.68143810 |
80 | SGK3 | 0.66736981 |
81 | ABL1 | 0.65389079 |
82 | CAMKK1 | 0.63930701 |
83 | RPS6KL1 | 0.62165176 |
84 | RPS6KC1 | 0.62165176 |
85 | HIPK2 | 0.60867294 |
86 | * EGFR | 0.60027748 |
87 | PRKCH | 0.59166303 |
88 | PIM2 | 0.58793142 |
89 | CDK19 | 0.58690533 |
90 | MOS | 0.58111534 |
91 | NME2 | 0.57967620 |
92 | EPHA3 | 0.54451996 |
93 | ABL2 | 0.51368962 |
94 | STK11 | 0.51295301 |
95 | TLK1 | 0.50979565 |
96 | PIK3CG | 0.50966322 |
97 | NLK | 0.50842602 |
98 | PAK4 | 0.50598189 |
99 | CDK9 | 0.49170219 |
100 | STK3 | 0.45705091 |
101 | KSR2 | 0.45090761 |
102 | FRK | 0.44262489 |
103 | CLK1 | 0.44134956 |
104 | MST1R | 0.42282775 |
105 | RPS6KA2 | 0.41168420 |
106 | PTK2B | 0.40664161 |
107 | DAPK2 | 0.40258530 |
108 | PDK1 | 0.40192016 |
109 | CDK4 | 0.39951865 |
110 | TRPM7 | 0.38656276 |
111 | MTOR | 0.38200735 |
112 | MAPK11 | 0.37031529 |
113 | PDPK1 | 0.36930433 |
114 | FYN | 0.36550292 |
115 | MAP3K5 | 0.36228484 |
116 | PRKAA2 | 0.35308602 |
117 | MAPK12 | 0.35094803 |
118 | MAP3K1 | 0.35083493 |
119 | PRKCD | 0.34530056 |
120 | MAP3K8 | 0.34118369 |
121 | CAMK4 | 0.33365247 |
122 | MAP2K4 | 0.32623415 |
123 | RPS6KA6 | 0.32184998 |
124 | MAPK4 | 0.32106340 |
125 | NEK2 | 0.31167969 |
126 | GSK3A | 0.30946269 |
127 | MAPKAPK2 | 0.30867362 |
128 | PDGFRB | 0.30180200 |
129 | STK4 | 0.30101497 |
130 | ALK | 0.30064318 |
131 | SGK2 | 0.29612734 |
132 | PRKCQ | 0.29401841 |
133 | ERBB4 | 0.28831901 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.84111481 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.95529593 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51251850 |
4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.49419774 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45160746 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39663539 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28428358 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24989484 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16090685 |
10 | Lysosome_Homo sapiens_hsa04142 | 2.13224986 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03791087 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 1.96924663 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.96480492 |
14 | Malaria_Homo sapiens_hsa05144 | 1.88632503 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83552969 |
16 | Measles_Homo sapiens_hsa05162 | 1.83124113 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80500503 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74765505 |
19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71723176 |
20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69050788 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.61567586 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.59634979 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58249836 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52688506 |
25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45666604 |
26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44486492 |
27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.41808195 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39346057 |
29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37382343 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34136559 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.32176069 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30007712 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28543324 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23690672 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.23651232 |
36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23429531 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23382624 |
38 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22896947 |
39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22062995 |
40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19449146 |
41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19356258 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.19262060 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.13441030 |
44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12430646 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12308327 |
46 | Allograft rejection_Homo sapiens_hsa05330 | 1.09005118 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.08388033 |
48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08198749 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 1.08031457 |
50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07259169 |
51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04563640 |
52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03845804 |
53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99557446 |
54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98547015 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90904947 |
56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86744086 |
57 | Asthma_Homo sapiens_hsa05310 | 0.86002395 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83571689 |
59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83018421 |
60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82489700 |
61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82349500 |
62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82145060 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81638385 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79010984 |
65 | Lysine degradation_Homo sapiens_hsa00310 | 0.78438623 |
66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78269863 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77199926 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.76711226 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74416843 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73713116 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.73482487 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73341310 |
73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72481522 |
74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69630695 |
75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69359856 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68337514 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67678701 |
78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66242689 |
79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65416352 |
80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65276274 |
81 | ABC transporters_Homo sapiens_hsa02010 | 0.63482255 |
82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61006268 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.60645254 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59421796 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59072628 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57303972 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53956321 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.53769687 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52464038 |
90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51543278 |
91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51094415 |
92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49736768 |
93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48378988 |
94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46585927 |
95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44953126 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44183326 |
97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44153360 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43740029 |
99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42837895 |
100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41226143 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41039427 |
102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40683351 |
103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40360949 |
104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40328781 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39551000 |
106 | Bladder cancer_Homo sapiens_hsa05219 | 0.38408947 |
107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38299493 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38287434 |
109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37979057 |
110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37539031 |
111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36956978 |
112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36761078 |
113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36720982 |
114 | Endocytosis_Homo sapiens_hsa04144 | 0.36325455 |
115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36205911 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34975557 |
117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34940317 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34862203 |
119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34498874 |
120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34183410 |
121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32706283 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.32626432 |
123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31333264 |
124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31155681 |